Clinical Trials Directory

Trials / Completed

CompletedNCT02897492

Rapid and Highly Sensitive Detection of Fluorescently-labeled Troponin in Patients Admitted With Chest Pain

Status
Completed
Phase
Study type
Observational
Enrollment
100 (actual)
Sponsor
Rambam Health Care Campus · Academic / Other
Sex
All
Age
18 Years – 120 Years
Healthy volunteers
Accepted

Summary

Patients with chest pain may have postponed or missed diagnosis of acute coronary events due to relatively late detection of troponin elevation. The study will investigate a new diagnostic method for early detection of even minimal troponin elevation in patients admitted with chest pain.

Detailed description

Patients with chest pain may have postponed or missed diagnosis of acute coronary events due to relatively late detection of troponin elevation. The study will investigate a new diagnostic method for early detection of even minimal troponin elevation in patients admitted with chest pain. A new diagnostic method will be applicated in the recent studies.

Conditions

Interventions

TypeNameDescription
OTHERBlood testing in a newly described methodTo exploit detection strategy termed "Magnetic Modulation Biosensing", or MMB) to develop a novel, low-cost platform that can detect biomarkers, such as proteins and specific DNA sequences, rapidly and directly from real samples at very low concentrations.

Timeline

Start date
2016-09-01
Primary completion
2019-03-01
Completion
2019-03-20
First posted
2016-09-13
Last updated
2019-03-28

Source: ClinicalTrials.gov record NCT02897492. Inclusion in this directory is not an endorsement.

Rapid and Highly Sensitive Detection of Fluorescently-labeled Troponin in Patients Admitted With Chest Pain (NCT02897492) · Clinical Trials Directory